retatrutide developer company Retatrutide, a new weight loss drug not available on the market yet, is showing promising results in trials. @DrLaPook explains it's doing much more than what current medications can Retatrutide Guide: Triple Agonist Research

Studies need to be done to better understand the changes of muscle after weight loss while on these new highly effective obesity medications. Advertisement Advertisement Sign up for our Health Essentials emails for expert guidance on nutrition, fitness, sleep, skin care and more

GLP-1 therapy works the same way for many patients, managing a metabolic condition rather than curing it

December 24, 2022

Liver fat content decreased by 44% in a subset of participants who underwent MRI imaging

Disclaimer: This article is intended for licensed medical professionals

This page covers projected timelines based on clinical trial progress